Examination of the Effectiveness of Diffusion Weighted Magnetic Resonance Imaging for Identifying Poor Prognosis in Patients With Rheumatoid Arthritis
|ClinicalTrials.gov Identifier: NCT01482507|
Recruitment Status : Completed
First Posted : November 30, 2011
Last Update Posted : April 6, 2018
|Condition or disease|
Assess DWI MRI in patients with early Rheumatoid Arthritis to determine whether the MRI method will assist in differentiating poor prognosis bone oedema more effectively than traditional T2 weighted MRI.
Aim 1: To compare DWI MRI with T2 weighted MRI for the discrimination of different types of bone oedema lesions in patients with early RA.
Aim 2: To examine the association between the presence of different types of bone oedema lesions detected on DWI MRI and T2 weighted MRI and the development of subsequent joint bone erosion as detected on i) MRI and ii) standard plain radiographs.
|Study Type :||Observational|
|Actual Enrollment :||10 participants|
|Official Title:||Examination of the Effectiveness of Diffusion Weighted Magnetic Resonance Imaging for Identifying Poor Prognosis in Patients With Rheumatoid Arthritis|
|Actual Study Start Date :||August 2011|
|Actual Primary Completion Date :||December 2014|
|Actual Study Completion Date :||December 2014|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01482507
|Australia, New South Wales|
|Optimus Clinical Research|
|Kogarah, New South Wales, Australia, 2217|
|Principal Investigator:||Paul Bird, Dr||Optimus Clinical Research|